Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional)

Department of Health and Human Services National Institutes of Health
Posted on

Scadenza delle domande

Tipo

Financial aid

Reference Number

PAR-22-222

The objective of this Funding Opportunity Announcement (FOA) is to support the continued development of new and innovative on-demand, event-driven, and long-acting (systemic and non-systemic) multipurpose prevention technologies (MPTs). It supports development of MPTs that prevent HIV infection and pregnancy (hormonal and non-hormonal methods); sexually transmitted infections (STI) and pregnancy; or multiple non-HIV STI or HIV/STI MPTs in cis and trans males and females of all ages. Applications for MPT development may involve pharmacokinetic (PK), pharmacodynamic (PD), safety and, drug-drug interactions (DDI) studies using drug development, and formulation science supported by animal model testing. Also supported are biobehavioral and behavioral/social studies to identify MPT user-desired rheological and biophysical factors (look, feel, effectiveness, safety, and duration of action) and other behavioral/social factors that could promote increased MPT adoption and use.
Categories: Income Security and Social Services, Health.

More Information

Posted on

Scadenza delle domande

Tipo

Financial aid

Reference Number

PAR-22-222

Stati Uniti